Concepedia

Lelisa Gemta

LG

Statistics

Publications

6

Citations

881

H-Index

6

Active since

2014

Affiliations

University of Virginia(Current)

University Hospital Regensburg

Duke University

Vanderbilt University Medical Center

Lelisa Gemta is an author at University of Virginia specializing in immunology, medicine, and oncology.

ORCID

Publications per year

2014–2020

6

Publications

6

Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma

Peter J. Siska, Kathryn E. Beckermann, Frank M. Mason et al. · JCI Insight · 2017 · 387 citations · Full text

, , +17

Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity

J. David Peske, Elizabeth D. Thompson, Lelisa Gemta et al. · Nature Communications · 2015 · 211 citations · Full text

, , +17

Impaired enolase 1 glycolytic activity restrains effector functions of tumor-infiltrating CD8 <sup>+</sup> T cells

Lelisa Gemta, Peter J. Siska, Marin E. Nelson et al. · Science Immunology · 2019 · 151 citations · Full text

, , +17

Tyrosine Kinase Inhibition in Leukemia Induces an Altered Metabolic State Sensitive to Mitochondrial Perturbations

Francesca Alvarez‐Calderon, Mark A. Gregory, Catherine Pham‐Danis et al. · Clinical Cancer Research · 2014 · 67 citations · Full text

, , +17

Modulation of PKM activity affects the differentiation of T <sub>H</sub> 17 cells

Scott M. Seki, Kacper Posyniak, Rebecca L. McCloud et al. · Science Signaling · 2020 · 39 citations · Full text

, , +17

1–5 of 6